Andåker L, Kling P A, Burman L G
Department of Surgery, Central Hospital, Norrköping, Sweden.
Acta Chir Scand. 1987 Jul-Aug;153(7-8):411-6.
A one-day prevalence study of resistance of faecal bacteria to 19 antibacterial agents was performed in 144 surgical inpatients. Most of the drug-resistant isolates were of aerobic and anaerobic species commonly seen in infections, which indicates that surveys of faecal flora can yield rapid information on local patterns of drug resistance in pathogens relevant to abdominal infection. In faecal bacteria the drug resistance pattern only weakly reflected the local antibiotic consumption. The amount of administered aminoglycosides was relatively small, and no gentamicin-resistant aerobes were found. Absence of resistance was found also for some of the newer agents not yet in clinical use (aztreonam, latamoxef, norfloxacin), but not for others (ceftazidime, ceftriaxone). Despite heavy use of fosfomycin and metronidazole, resistance had not emerged among aerobic and anaerobic bacteria, respectively. Imipenem was unique in inhibiting growth of all aerobic and anaerobic faecal bacteria, in the studied patients with the single exception of a strain of Enterobacter.
对144名外科住院患者进行了一项为期一天的粪便细菌对19种抗菌药物耐药性的患病率研究。大多数耐药菌株属于感染中常见的需氧菌和厌氧菌,这表明对粪便菌群的调查可以快速获取与腹部感染相关的病原体的局部耐药模式信息。在粪便细菌中,耐药模式仅微弱反映了当地抗生素的使用情况。氨基糖苷类药物的使用量相对较小,未发现对庆大霉素耐药的需氧菌。一些尚未临床使用的新型药物(氨曲南、拉氧头孢、诺氟沙星)也未发现耐药情况,但其他药物(头孢他啶、头孢曲松)则不然。尽管大量使用了磷霉素和甲硝唑,但需氧菌和厌氧菌中分别尚未出现耐药情况。亚胺培南的独特之处在于,在所研究的患者中,它能抑制所有需氧和厌氧粪便细菌的生长,仅一株肠杆菌属菌株除外。